Generex Biotechnology Announces Satisfaction of Debt Obligation
Retires $3,150,972 in debt and satisfies all associated obligations Payment in GNBT restricted common shares at the July 16, 2019 closing price MIRAMAR, Fla., July 19, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT …